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AbstrACt
Introduction Gestational diabetes mellitus (GDM) carries 
prenatal and perinatal risk for the mother and her offspring 
as well as longer-term risks for both the mother (obesity, 
diabetes, cardiovascular disease) and her child (obesity, type 2 
diabetes). Compared with women without GDM, women with 
GDM are twice as likely to develop perinatal or postpartum 
depression. Lifestyle interventions for GDM are generally 
limited to physical activity and/or nutrition, often focus 
separately on the mother or the child and take place either 
during or after pregnancy, while their results are inconsistent. 
To increase efficacy of intervention, the multifactorial origins of 
GDM and the tight link between mental and metabolic as well 
as maternal and child health need to be heeded. This calls for 
an interdisciplinary transgenerational approach starting in, but 
continuing beyond pregnancy.
Methods and analysis This randomised controlled trial 
will assess the effect of a multidimensional interdisciplinary 
lifestyle and psychosocial intervention aimed at improving the 
metabolic and mental health of 200 women with GDM and 
their offspring. Women with GDM at 24–32 weeks gestational 
age who understand French or English, and their offspring and 
partners can participate. The intervention components will be 
delivered on top of usual care during pregnancy and the first 
year postpartum. Metabolic and mental health outcomes will 
be measured at 24–32 weeks of pregnancy, shortly after birth 
and at 6–8 weeks and 1 year after childbirth. Data will be 
analysed using intention-to-treat analyses. The MySweetHeart 
Trial is linked to the MySweetHeart Cohort ( clinicaltrials. gov/ 
ct2/ show/ NCT02872974).
Ethics and dissemination We will disseminate the 
findings through regional, national and international 
conferences and through peer-reviewed journals.
trial registration number NCT02890693; Pre-results.
IntroduCtIon
definition and prevalence of gestational diabetes 
mellitus (GdM)
GDM is characterised by glucose intolerance 
diagnosed during pregnancy not fulfilling the 
criteria for diabetes.1 2 It often resolves after 
childbirth,1 2 although up to 40% of women 
have prediabetes in the early postpartum 
period.3 In Switzerland, the prevalence of 
GDM is 10.8%.4 
Morbidity of GdM and related conditions
GDM carries prenatal and perinatal risk for 
the mother and her child and is also linked 
to postnatal risks. Long-term maternal risks 
include a 30%–70% GDM recurrence, a 
7-fold higher 5–10 year risk of type 2 diabetes 
and an increased risk of metabolic syndrome 
and cardiovascular disease.5–8 Compared with 
women without GDM, women with GDM are 
twice to four times9 as likely to develop ante-
natal or postpartum depression and approx-
imately one-third of women with recent 
GDM develop postpartum depression.10 
Postpartum depression leads to an increase 
in comfort eating and a decrease in physical 
strengths and limitations of this study
 ► The study will test the effects of a novel 
multidimensional interdisciplinary lifestyle 
and psychosocial intervention for women with 
gestational diabetes mellitus.
 ► The intervention focuses on both metabolic and 
mental health, of the mother and her offspring, 
which  starts during pregnancy and continues 
beyond birth.
 ► The intervention draws on theories of health 
behaviour change through motivational and 
systemic approaches.
 ► Methodological rigour, including concealment of 
random allocation, blinded outcome assessors, 
regular monitoring and prospective trial registration 
and publication, should limit risk of bias.
 ► Unblinded participants and clinicians for some of the 
secondary outcomes may increase the risk of bias.
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activity,11 thus putting the women at higher risk of weight 
gain and future diabetes.10
Regarding the child, the importance of the intrauterine 
and early postnatal environments for metabolic program-
ming and modifications of the epigenome is increasingly 
recognised,12–14 particularly for metabolic diseases such as 
obesity and diabetes.15 Thus, GDM is related to macro-
somia at birth (>4 kg), to excess body fat and (central) 
obesity and to insulin secretion in infants and children, 
the obesity being in part mediated by maternal body 
mass index (BMI) or birth weight.16–23 Intrauterine expo-
sure to GDM also doubles the risk for subsequent type 2 
diabetes in offspring compared with offspring of mothers 
with a high genetic predisposition for type 2 diabetes, but 
with normal glucose tolerance during the index preg-
nancy.24 Maternal prepregnancy overweight and excessive 
gestational weight gain also predict high birth weight and 
adiposity during infancy.12 25 This is highly relevant, as up 
to 60%–70% of women with GDM are overweight or obese 
before pregnancy.26 Finally, maternal lifestyle behaviour 
such as a high fat diet or lack of physical activity during 
pregnancy can influence offspring adiposity independent 
of maternal obesity.12 27
The higher risk for maternal postpartum depression is 
also associated with reduced parenting skills, which may 
have negative consequences for the development of the 
child.28–30 Parents of obese children may lack effective 
parenting skills providing both a consistent structured 
frame and emotional support.31 In women with GDM, 
psychosocial vulnerability including low levels of social 
and family networks is associated with more adverse 
neonatal outcomes, especially increased birth weight.32 
Thus, there is a tight interaction between maternal life-
style, weight status, mental health, social support as 
well as between maternal and child’s overall health. In 
view of the high worldwide prevalence of (childhood) 
obesity and associated metabolic problems, this close link 
between maternal and child metabolic health and the 
resulting vicious cycle are very relevant.33 34 Because of 
the deleterious impact of GDM and lifestyle during preg-
nancy on the health of the mother and her offspring, it 
is crucial to intervene during the prenatal, perinatal and 
postnatal period.
Modifiable risk factors of GdM
Risk factors for GDM that are modifiable during preg-
nancy include excessive weight gain which is a very 
frequent phenomenon that is observed in a majority 
of pregnant women (in up to 75% of pregnancies).35 36 
Further modifiable risk factors include lifestyle behaviours 
such as low levels of physical activity, high fat and animal 
protein consumption, high intake of added sugar and low 
intake of vegetable and fruit fiber.37 Regular food intake 
and avoidance of snacking can have beneficial effects on 
weight and glucose tolerance, but this has mostly been 
tested outside of pregnancy.38–42 Another key factor is 
mental health. Higher stress exposure and perceived 
stress during pregnancy have been linked to GDM and/or 
higher glucose levels in women.43–45 Psychological stress 
and negative life events can be associated with higher sali-
vary cortisol levels during pregnancy, which might relate 
to higher glucose levels.46 Higher depression scores early 
in pregnancy also increase the risk for GDM.9 47 On the 
other hand, social support has been shown to be protec-
tive regarding mental health and depression in partic-
ular.9 48 49
Physical activity, nutrition and depression are inter-
linked. Physical activity can reduce symptoms of depres-
sion,50 and there is a two-directional relationship between 
unhealthy eating and the incidence of symptoms of 
depression.51 Mindfulness and mindful eating can have 
a beneficial impact on weight loss and food cravings.52–54
Prior studies having evaluated lifestyle interventions in GdM
Most interventions in GDM focus either on dietary or on 
physical activity changes and only last during pregnancy.
 Dietary advice is recommended for all women with GDM 
to improve glycaemic control and to provide adequate 
nutrition.1 Of the few existing trials, the majority focused 
on either low carbohydrate or low glycaemic index foods. 
Results were not consistent and effect sizes were small, but 
low glycaemic diets, sometimes in combination of higher 
fibre intake, were found to have a favourable impact 
on insulin requirements, birth weight and/or maternal 
weight gain.55–57 A recent Cochrane review found that 
more evidence is needed to assess the effects of different 
types of dietary advice to give to women with GDM.58 
As fat, especially saturated fat, is a risk factor for both 
GDM and type 2 diabetes, decreasing animal fat intake 
represents an interesting novel approach.59–62 Indeed, 
a high-complex carbohydrate/low-fat diet improved 
glycaemic values and insulin resistance in women with 
GDM as well as infant adiposity in a pilot study of women 
with GDM.63 Regarding eating behaviour, a recent inter-
vention focusing on mindfulness-based eating awareness 
that aimed at increasing awareness of inner cues, such as 
hunger and satiety, at identification of emotional eating 
and eating triggers, had a beneficial impact on glycaemic 
control.64 65
Although recommended for GDM treatment, guide-
lines do not specify the type of physical activity or its 
timing in regards to meal intake.66 67 Aerobic and resis-
tance exercise can be accomplished during pregnancy 
in the absence of contraindications,68 but motivation, 
compliance, perceived health and lack of time appear to 
be major limiting factors.48 69 A recent review concluded 
that physical activity, both aerobic and resistance exer-
cise, may improve glycaemic control and/or limit insulin 
use in women with GDM.70 Regular physical activity can 
also limit pregnancy weight gain, stabilise maternal mood 
and reduce fetal fat mass (FM) and physiological stress 
responses in the offspring.27 69 71
To our knowledge, there are no evidence-based psycholog-
ical interventions for women with GDM and no international 
guidelines for psychosocial management exist,72 although 
evidence shows that inclusion of partners can be helpful.73 74
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Postpartum follow-up and interventions
Due to the increased risk of development or persistence 
of prediabetes and diabetes, management of women 
with GDM in the postpartum period is essential. The 
American Diabetes Association, the American College 
of Obstetricians and Gynaecologists and the National 
Diabetes Education Program recommend testing within 
4–12 weeks postpartum with a 2 hour 75 g oral glucose 
tolerance test (oGTT).2 75 76
Weightloss is an important predictor to prevent diabetes 
in this high-risk population. Thus, in the Diabetes Preven-
tion Program, weight loss after GDM reduced future 
diabetes incidence by 16% for every kilogram lost.77 The 
Nurses Health Study found that healthy diet patterns 
such as a Mediterranean diet, a Dietary approaches to 
stop hypertension (DASH) pattern diet or an Alterna-
tive Healthy Eating diet reduced diabetes incidence by 
40%–57% in women who had GDM 14 years before.78 
Evidence of the Gestational Diabetes’ Effects on Moms 
study shows that a lifestyle intervention that starts during 
pregnancy and continues postpartum is feasible and may 
prevent pregnancy weight retention and help overweight 
women lose weight.79 80
In the postpartum period after GDM, low social support 
was related to low adherence to a healthy lifestyle, thus 
contributing to an increased risk of type 2 diabetes.81 
In another study, social support was a key factor for the 
adoption of physical activity among women after GDM.82 
Finally, integrating partners into the intervention helped 
to maximise participation in an intervention that aimed 
to prevent type 2 diabetes after GDM.74
Prevention strategies for the child
Offspring of women with GDM are at higher risk for child-
hood obesity83 and intervening in the early postpartum 
period is therefore essential. Several modifiable risk or 
protective factors have been identified, such as infant 
feeding mode (bottle vs breastfeeding), parental respon-
siveness to infant feeding cues and infant distress, the age 
of bottle weaning, timing of the introduction of solid food, 
sweetened beverage consumption and lack of physical 
activity.84–88 Inactivity can delay motor development and 
further increases the risk for early childhood obesity.85 89–91
Parenting skills interventions that focus on these factors 
provide anticipatory guidance and teach parents how to 
identify and respond appropriately to infant cues and 
distress to positively influence self-regulatory capacities, 
well-being and the developing control of the infant’s food 
intake in order to avoid eating in the absence of hunger 
have shown beneficial results.84 85 92 93
theoretical framework for behaviour change interventions
The chosen theoretical framework for the behaviour 
change interventions is the Health Action Process 
Approach (HAPA).94
The HAPA distinguishes between a motivational and a 
volitional phase of behavioural change. In the motivational 
phase, the process of forming an intention to engage in 
a health behaviour takes place. Being aware of a personal 
risk due to the unhealthy behaviour, perceiving more 
benefits than disadvantages of changing the behaviour 
(outcome expectancies) and believing in one’s own abili-
ties to change the behaviour (self-efficacy) are the factors 
that the HAPA specifies to increase the likelihood of a 
behavioural intention to change the behaviour. After an 
intention has been set, the individual enters the volitional 
phase. Here, action control, action planning, coping plan-
ning and again self-efficacy are assumed to be crucial for 
translating the intention into behaviour. Action control 
and its components (ie, the awareness of one’s own stan-
dards for the new behaviour, self-monitoring and regula-
tory effort in case of a discrepancy between the intended 
and the actual behaviour) have been demonstrated in 
several populations and across several behaviours, among 
them physical activity and diet, to be effective in promoting 
behavioural change.95 Moreover, action planning and 
coping planning are crucial postintentional variables in 
the HAPA. Action planning, which is also known as imple-
mentation intentions,96 97 refers to if-then plans regarding 
the exact planning of when, where and how a behaviour 
will be implemented. Implementation intentions have 
been demonstrated to be an effective tool of behavioural 
change in numerous settings and behaviours, displaying 
medium to strong effect sizes.98–100 Coping plans refer 
to plans that specify a critical barrier to the intended/
planned behaviour and a specific strategy on how to cope 
with this barrier.101 A recent systematic review attests that 
the combination of action planning and coping planning 
seems to be most effective for behavioural change.102 
Self-efficacy has also been shown to be a crucial factor in 
health behaviour change across different behaviours and 
different populations.
development of a complex multidimensional interdisciplinary 
lifestyle intervention
Given that single risk factor interventions have shown 
limited efficacy, and considering the multifactorial origins 
of GDM, complex interdisciplinary approaches that start 
in pregnancy and continue postpartum, targeting both 
the mother and the child could be more efficient. This 
is especially important with regard to the intergenera-
tional transmission of risk.103 Some authors specifically 
called for the need to integrate psychological support in a 
lifestyle intervention.104 Typical characteristics of complex 
interventions are that they contain several interacting 
components, their high number of outcomes and that 
a high degree of flexibility or tailoring of the interven-
tion is permitted.105 Furthermore, complex interventions 
work best if tailored to local circumstances rather than 
completely standardised.105
Aims
This study aims to test the effect of an evidence-based, 
complex interdisciplinary lifestyle and psychosocial 
continuous prepartum and postpartum intervention in 
women with GDM on maternal and offspring metabolic 
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and mental health outcomes up to 1 year postpartum. 
It also aims to investigate longitudinal associations, 
thus increasing the understanding of the development 
of maternal and child obesity, glucose intolerance and 
mental health problems.
MEthods
study design
We will conduct a monocentric superiority open 
Randomised Controlled Trial (RCT) with minimal risk 
aiming to test the effect of a multidimensional interdis-
ciplinary lifestyle and psychosocial intervention for preg-
nant women with GDM and their offspring, compared 
with treatment-as-usual (figure 1).
study population, recruitment, group allocation and blinding
Women diagnosed with GDM according to IADPSG 
criteria106 107 will be recruited (1) in our diabetes and 
pregnancy clinic, where patients both from the Univer-
sity Hospital Vaud (CHUV) antenatal care clinic and 
from obstetricians in private practice are referred to 
or (2) referred to our clinic for the study from diabe-
tologists in private practice and from regional hospi-
tals in the canton Vaud. Following their first clinical 
appointment, the study coordinator will explain the 
study and give the information sheet to the patient. 
Participating women will receive for their time, effort 
as well as the fees for their frequent travels CHF 250 
at the 6–8 week postpartum visit and then CHF 200 at 
the 1 year visit.
Figure 1 Trial flowchart.
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The inclusion criteria are as follows: pregnant women 
aged ≥18 years, with GDM at 24–32 weeks of gestation 
and understanding French or English. Women on strict 
bed-rest, with pre-existing DM or current episode of 
severe mental disorder will be excluded.
The allocation ratio of randomisation is 1:1, using the 
block randomisation method (blocks of 4) after stratifica-
tion for the place of the usual care (at the CHUV or the 
respective private diabetologist/regional hospital). Thus, 
each referral centre represents its own control. However, 
all intervention components and all the evaluations take 
place at the CHUV hospital. For allocation of the partici-
pants, a computer-generated list of random blocks is used 
(https://www. sealedenvelope. com/ simple- randomiser). 
The allocation sequence will be concealed from the 
research staff assessing the primary outcomes in sequen-
tially numbered, opaque, sealed envelopes. Envelopes 
will be opened only after the enrolled participants gave 
signed consent and completed all baseline assessments. 
Assessors of primary outcomes and the statistician will be 
blind to group allocation.
Control group
The control group will receive treatment-as-usual, which is 
based on the current guidelines of the American Diabetes 
Association2 and of the Endocrine Society.1 Patients are 
first seen at 24–32 weeks of gestation by a physician and/
or a specialised nurse practitioner who will then provide 
follow-up until childbirth. During the first visit, patients 
learn about GDM and how to perform self-control of 
blood glucose 4 times a day (fasting and 2 hours post-
prandially).1 108
Regarding the weight, lifestyle and mental health goals, 
details are provided in tables 1A and B. Standard advice 
about gestational weight gain according to the Institute of 
Medicine recommendations109 110 will be given. Patients 
have one appointment with a registered dietician in order 
to receive individualised dietary advice, with a focus on 
how to distribute carbohydrate intake over several meals 
and snacks, limit the intake of free sugars to less than 10%, 
and increase fibre intake to up to 30 g per day. Patients 
are encouraged to increase physical activity according 
to the Endocrine Society Guidelines.1 If despite lifestyle 
measures, glucose values remain above targets,1 2 twice 
or more during a 2-week period,108 metformin or insulin 
treatment is installed depending on glucose values (eg, 
insulin in case of relatively high glycaemic values) and 
patient preference.111
In the postpartum period, patients then undergo a 75 g 
oGTT at 6–8 weeks postpartum and are seen afterwards 
by the physician and a dietician jointly to discuss results 
and further management and provide general advice on 
lifestyle measures.1 2 Patients then resume usual care by 
their healthcare provider outside of the clinic.
The frequency of blood glucose self-control, the thresh-
olds for initiating treatment, the choice of the medical 
treatment and the first visit with the dietician will be the 
same in the control and in the intervention group.
Intervention group
The complex, multidimensional, interdisciplinary life-
style and psychosocial intervention will be offered on 
top of usual care. Details for the goals of the interven-
tion group are provided in tables 1A and B. All goals will 
be individually tailored and set by the respective experts 
(dietician and physiotherapist) during the face-to-face 
prepartum consultations, based on the patients’ context 
and capacities112 and transmitted to the coach (see 
below). The goals will also be discussed during bimonthly 
interdisciplinary meetings in the postpartum period and 
exchanges regarding further adaptations.83–86 89–93 113–124
Counselling about gestational weight gain according 
to the Institute of Medicine recommendations and about 
weight retention will be given.109 110 In addition to the 
dietary goals set in the control group, the intervention 
aims to reduce intake of total lipid intake,125 saturated 
fat,126 to prioritise higher quality fats such as monounsat-
urated fat present in the Mediterranean,127 128 DASH and 
plant-based diets and to reduce red or processed meat 
intake.127 It also aims to encourage mindful eating129–131 
and regular, structured eating.1 The intervention also 
includes the promotion of continuous breastfeeding for 
at least 6 months. The intervention encourages aerobic 
and resistance physical activity66 68 132 133 and aims to 
reduce sedentary behaviour.134
Regarding the psychosocial part,135 patients will be 
screened for depression at study beginning, at 6–8 
weeks, at 7 months postpartum and at 1 year postpartum. 
According to a stepped care approach (based on the 
patient’s Edinburgh Postnatal Depression Scale (EPDS) 
score), facilitated self-help with the coach or individual 
cognitive behavioural therapy sessions with the clin-
ical psychologist will be offered.135 Common elements 
are: (1) challenge most unhelpful negative cognitions, 
(2) schedule at least one pleasurable activity per day, 
(3) increase social contacts, (4) improve sleep routine, 
(5) identify most stressful situations and apply cogni-
tive behavioural strategies to improve their manage-
ment.135 136 Patients who require a psychiatric evaluation 
will be referred to a psychiatry liaison service. Treatment 
goals for the offspring focus on diet, breastfeeding, 
nutrition, physical activity137 and emotional regulation, 
all of which will be addressed via psychoeducation and 
parenting training (see tables 1A and B).
The intervention will take place during pregnancy and 
during the first year postpartum and will be delivered 
in individual sessions during the prepartum period with 
members of the multidisciplinary team, in 3–4 monthly 
individual interdisciplinary sessions in the postpartum 
period covering both the mother and the child or during 
group workshops. Throughout the pregnancy and up 
to 1 year postpartum, patients will be accompanied and 
supported by a lifestyle coach (with regular supervision by 
a clinical psychologist) who will monitor adherence to the 
intervention, provide booster messages, identify barriers 
and facilitators, discuss action plans, provide support and 
teach strategies to work towards the individual goals. The 
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coach will offer different behaviour change techniques138 
targeting the HAPA90 constructs relevant for the respec-
tive phase participants are in. Depending on the needs 
and the progress of participants, the content of the theo-
ry-based interventions will be tailored to the individuals. 
Self-monitoring by the patient will help to clarify the situ-
ation and adjust the goals. During pregnancy, the coach 
will have approximately 15 min of biweekly contact (by 
phone, videophone and/or face to face after clinical 
visits). During the first year postpartum, the coach will 
have phone/videophone contact with the mother every 
3 weeks until 6 months and then monthly. Patients will 
receive a folder with written materials and resources and 
worksheets or text messages (according to preferences) 
to monitor their personalised tailored goals and action 
plans in the different domains throughout the study 
period. Close collaboration with paediatricians, obstetri-
cians and existing healthcare networks that form part of 
the patients’ usual clinical care will be ensured.
Social support will be encouraged on three levels.139–141 
First, partners will be invited to attend individual and 
group sessions during both the prepartum and post-
partum period. If partners are unable to attend those 
sessions, a phone/videophone contact at the end of 
the sessions will be offered. Second, small peer support 
groups will be formed during the prepartum and post-
partum workshops. Third, the coach will also transmit 
information about other local support offers and will 
refer the patient to a lactation consultant, if desired by 
the patient. There are no specific other intervention parts D
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Table 1B Goals for the infant up to 1 year (targeted through 
parent education)
Domains Intervention group Control group
Diet Breastfeeding: encourage 
continuation for at least 
6 months184
Soothing: propose alternative 
methods than feeding85 92 121
Hunger and satiety: recognise the 
respective cues92 120
Food: introduce solid food after at 
least 4–6 months of age185
Provide general 
recommendation 
for breastfeeding184
Physical 
activity
Physical activity: encourage 
physical activity during waking 
hours, reaching 180 min/day at 
1 year of age137
Sedentary behaviour: no screen 
time137
No specific 
intervention
Mental 
health
Parental regulation of infant 
distress and self regulation 
capacity: increased through 
parent education during prenatal 
and postnatal workshops and 
postpartum interdisciplinary 
sessions and reinforced by 
coach85 92
No specific 
intervention
BMI, body mass index; EPDS, Edinburgh Postnatal Depression 
Scale; RPE, rate of perceived exertion. 
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for the partners except their integration in the maternal 
and offspring goals, which include a family approach.
Primary outcomes
The primary outcomes are differences between the inter-
vention and the control groups in (1) the decrease in 
maternal weight (calibrated Seca scale) between 24–32 
weeks gestational age (GA) and 1 year postpartum and 
(2) attenuation in maternal symptoms of depression 
(EPDS) during the same time period.
secondary outcomes
Maternal outcomes
The following lifestyle behaviours will be measured: 
carbohydrate and fat intake (Food Frequency Ques-
tionnaire (FFQ), see below), eating behaviour (French 
Intuitive Eating Scale (IES), see below), breastfeeding 
(self-report), physical activity (accelerometer GENE-
Activ), sleep (Pittsburgh Sleep Quality Index (PSQI), see 
below). Aerobic fitness will be estimated using the Chester 
step test (see below) and muscular fitness will be assessed 
with the hand grip strength using a Jamar dynamometer 
(see below). Body composition measures include bioelec-
trical impedance analysis (BIA), the sum of four skin-
folds (Harpenden callipers) as well as Dual-Energy-X-ray 
absorptiometry (iDXA device, GEHC-Lunar, Madison, 
Wisconsin, USA). Cardiometabolic laboratory variables 
and miRNA will be measured (for more details, see Di 
Bernardo et al142).
Additional mental health indicators include anxiety 
(Anxiety subscale of the Hospital Anxiety and Depression 
Scale (HADS), see below), depression (EPDS and Whooley 
questions, see below), well-being (WHO Well-Being 
Index, see below), social support (Medical Outcomes 
Study Social Support Survey-short form (mMOS-SS), see 
below) and parenting stress (Parenting Stress Scale-short 
form (PSI-SF), see below).
Offspring outcomes
Cardiometabolic laboratory variables and miRNA will be 
measured in the cord blood (for more details, see Di 
Bernardo et al142).
 Body composition measures include height, weight (stan-
dardised tools for infants), BIA and the sum of four skin-
folds (Harpenden callipers).
Mental health indicators include self-regulation (Diffi-
cult Child subscale of the Parenting Stress Index-Short 
form, see below) and sleep (Brief Infant Sleep Question-
naire (BISQ), see below).
data collection and visits
The study started in September 2016. The participation 
in the study is voluntary and involves a sequence of events 
and measurements as summarised in table 2.
At 24–32 weeks GA, baseline assessments are carried out 
(visit 1), including the validated questionnaires, physical 
activity and fitness measures, body composition assess-
ments and laboratory variables. If the women agree, their 
partners are also informed about the study and invited 
to participate using a separate information sheet and 
consent form. Once they have signed a separate consent 
form, research staff will measure the partner’s weight 
and height and ask him to complete validated self-report 
questionnaires (table 2).
During childbirth (visit 2), maternal blood will be drawn 
at the entry into the delivery room. After childbirth, blood 
will be drawn from the cord following clamping and 
birth weight will be recorded. Offspring birth weight and 
height will be collected from the hospital birth record.
At 6–8 weeks postpartum (visit 3), while attending a 
clinical appointment, women will be asked to complete a 
series of validated self-report questionnaires online, and 
physical activity and fitness measures, body composition 
assessments and laboratory variables will be measured. 
They will undergo a 75 g oGTT with blood sampling. 
Body composition assessments of their offspring will be 
assessed.
At 1 year postpartum (final visit, visit 4), participants 
will be asked to complete a series of validated self-report 
questionnaires online, and physical activity, aerobic and 
muscular fitness, body composition and laboratory vari-
ables will be measured. Women, who sign an additional 
consent, will also undergo Bone Densitometry (DEXA) 
measures for more detailed body composition. They will 
undergo a 75 g oGTT with blood sampling and blood 
pressure (three measures) will be measured. Body compo-
sition measures of their offspring will again be assessed.
Partners
Partners of participating women who also agree to partic-
ipate will be asked to complete validated questionnaires 
and body composition assessments at study entry and 
study end (when the women are at 24–32 weeks GA and 
at 1 year postpartum, respectively).
Measures
All measures and their timings are listed in detail in 
table 2.
Self-report questionnaires: mother and partner
Symptoms of depression in the preceding 7 days are 
assessed with EPDS,143 which has been validated for preg-
nant women.144 Each item is scored on a 4-point scale, 
the minimum and maximum total scores being 0 and 30, 
respectively. The EPDS has been validated in a French 
sample and good psychometric properties have been 
reported.145 The original authors suggested a cut-off score 
of 12.5 as an indication of clinically significant depression 
but others reported that a score of 10 was the most useful 
cut-off in a French sample of postnatal women.145
Exposure to life events is measured with the Life Events 
Questionnaire (see below), in which participants are given 
a list of three negative pregnancy-related major events 
(suspected growth retardation, vaginal bleeding, prema-
ture contractions) as well as 10 negative pregnancy-unre-
lated major life events (death of someone they were close 
to, serious illness, exposure to abuse, exposure to violence, 
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serious accident, unemployment, disability, alcohol/drug 
abuse, divorce, moving house) and have to indicate whether 
they have been exposed to any of these events in the last 12 
months.146 147
Carbohydrate and fat intake is assessed with the FFQ.148 149 
The FFQ comprises 97 items listing different types of food 
and drinks (tea, butter, tomatoes, chicken and so on) and 
six available spaces which allow the person to write any 
additional food or drinks she/he might have taken over a 
4-week period. Each item is rated for frequency of use on a 
6-point Likert scale ranging from 1 ‘never in the past 4 weeks’ 
to 6 ‘twice a day’. The items are also rated on a quantity 
scale which allows the person to compare the portion they 
took in comparison with a reference portion (ie, 150 g, one 
piece and so on) with three response choices: ‘less’, ‘same’ 
or ‘more’.
Eating behaviour is measured with the French IES,150 151 
assessing an individuals’ tendency to follow their physical 
hunger and satiety cues when determining when, what 
and how much to eat.152 In the current study, the IES was 
modified by taking out the unconditional permission to eat 
scale, as women with GDM are given strict diet counselling. 
Women respond using a 5-point Likert scale ranging from 
1 ‘strongly disagree’ to 5 ‘strongly agree’. To calculate the scale 
scores, negative items are reversed, so that high scores on 
the total measure and subscales indicate greater intuitive 
eating. The individual scores of items under each subscale 
are then summed to obtain subscale scores ranging from 1 
to 5. The French version of the IES-2 demonstrated good 
psychometric properties.151
Anxiety symptoms are assessed with the HADS,153–155 
which has seven items measuring state-anxiety in the last 
7 days. Each item is scored from 0 to 3, with higher scores 
indicating greater anxiety. Scores from 8 to 10 indicate 
possible clinical disorder and scores between 11 and 21 
indicate probable clinical disorder. Furthermore, it may be 
used as a measure of symptom severity from normal (0–7), 
mild (8–10), moderate (11–14), to severe (15–21). The 
HADS has good psychometric properties.154
Well-being is measured with the WHO Well-Being Index 
(WHO-5),156 which consists of 5 questions assessing the 
subjective well-being of the respondents. The items are 
measured on a 5-point Likert scale ranging from 0 ‘at no 
time’ to 5 ‘all of the time’. The scale has adequate validity 
both as a screening tool for depression and as an outcome 
measure in clinical trials and has been applied successfully 
across a wide range of study fields. The scale has been used 
most extensively in endocrinology156 and has good psycho-
metric properties in French.157
Parenting stress is assessed with the PSI-SF.158 It has 36 
items and consists of three subscales that assess parental 
distress, dysfunctional parent–child interactions and 
child difficulties. Items are rated using a 5-point Likert 
scale from 1 ‘totally agree’ to 5 ‘totally disagree’. The PSI has 
good psychometric properties.159
Sleep duration and quality are measured with the PSQI,160 
which has 19 items and measures retrospective sleep quality 
and disturbances over a 1-month period. It discriminates 
between good and poor sleepers and provides a brief, clin-
ically useful assessment of multiple sleep disturbances. The 
19 items are grouped into seven equally weighted compo-
nent scores: Subjective Sleep Quality, Sleep Latency, Sleep 
Duration, Habitual Sleep Efficiency, Sleep Disturbances, 
Use of Sleeping Medication and Daytime Dysfunction. 
Items 1–4 are free entry of: usual bed and wake times, 
minutes of total sleep time and sleep latency (minutes). 
Items 5–18 are rated on a 4-point Likert scale responses 
pertaining to problem frequency: ranging from 0 ‘not 
during the past month’ to 3 ‘three or more times a week’. Item 19 is 
rated on a 4-point Likert scale rating of overall sleep quality 
ranging from 0 ‘very good’ to 3 ‘very bad.’ All component 
scores range from 0 to 3. The Global Score ranges from 0 
to 21, with a higher score indicating poorer sleep quality 
and a cut-off score of >5 distinguishing poor sleepers from 
good sleepers. The questionnaire is validated in French.160 
The English questionnaire was retrieved directly from the 
author.161
Social support is measured with the mMOS-SS,162 which 
has two subscales assessing emotional and instrumental 
social support composed of four items to identify poten-
tially modifiable social support deficits. It has good psycho-
metric properties162 and was translated into French.163
Food to soothe is assessed with the Food to Soothe Ques-
tionnaire,87 the first subscale of the Baby's Basic Needs 
Questionnaire.87 It measures parents’ likeliness to use 
food to soothe their child by 33 items with a Likert scale 
ranging from 1 to 5. Twenty-six items present scenarios 
in which parents might use food to soothe. Seven items 
measure the use of food to encourage/discourage child 
behaviour. Five items are specified as ‘other’ so that the 
parents can fill in specific scenarios that might not be 
addressed in the questionnaire. There are also two more 
questions inviting parents to share more information 
about the use of food to soothe and the use of food to 
encourage or discourage behaviours.87 The scales were 
retrieved by personal communication with the author164 
and translated into French using standard techniques.163
Parental response to hunger/satiety clues is assessed 
with the Infant Feeding Style Questionnaire: Satiety 
subscale,165 designed to assess parental feeding practices. 
This parent-report measure consists of five subscales 
that tap parental control practices and attitudes in child 
feeding.87 In this study, we use the satiety subscale. Two of 
the items probe beliefs and are coded on a 5-point Likert 
scale ranging from 1 ‘disagree’ to 5 ‘agree’. The five other 
items probe behaviours and are coded on a 5-point Likert 
scale ranging from 1 ‘never’ to 5 ‘always’. The scales were 
obtained directly from the author166 and translated into 
French using standard techniques.163
Self-report questionnaires: offspring
Offspring sleep duration and quality are measured with 
the BISQ.167 The role of the responder is asked as 
well as the age, gender and birth order of the child. 
The parent rates their child's nocturnal sleep dura-
tion, daytime sleep duration, number of night waking, 
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duration of wakefulness during the night hours, 
nocturnal sleep-onset time, settling time, method of 
falling asleep, location of sleep and preferred body 
position during the past week. It has 14 items, which 
all have specific scoring measures related to the type 
of question. BISQ scores correlate significantly with 
sleep measures derived from actigraphy and sleep 
diaries.167 The scales were obtained directly from the 
author168 and translated into French using standard 
techniques.163
Offspring self-regulation is assessed with the PSI-SF158 
(see above).
Physical activity and fitness measures
Physical activity (total physical activity and its intensity) 
is assessed using an accelerometer (GeneActiv) that is 
worn on the right wrist during 10 consecutive days.169
The Chester Step Test, a multistage submaximal 
exercise test, is performed to estimate aerobic fitness 
(maximal oxygen uptake (V’O2max)).
170 Before starting 
the test, patients are instructed and experience a 30 s 
familiarisation. During the test, the step rate (assessed 
by an audiotape) starts at 15 step/min and increases 
of 5 step/min every 2 min. Patients are asked to step 
up and down for a maximum of 10 min. Step height 
(15, 20 or 25 cm) can be adapted depending on the 
physical characteristics and/or activity level of the 
patients. Heart rate (HR) and rate of perceived exer-
tion (RPE) on Borg’s scale are monitored at the end 
of each 2 min stage. The test is stopped when patients 
reach 80% of the estimated HRmax (220-age), when 
RPE≥15 or when the patient shows signs of distress 
during the test. The VO2max is then estimated using a 
standardised equation. The Chester step-test was vali-
dated against indirect calorimetry and demonstrated 
reasonable validity.171
Muscular fitness is assessed with a hand grip strength 
dynamometer (Jamar dynamometer) following stan-
dard procedure.172 Before starting the test, patients 
are instructed on the correct use of the dynamom-
eter (hand and wrist position during squeezing). 
Then, patients are seated in a chair and are asked 
to squeeze the dynamometer as tightly as possible. A 
verbal encouragement is given during the test. Three 
measures are taken for each hand and the highest 
value is considered for analysis.
Physical examination: body composition assessments
Weight is measured in mothers, fathers as well as their 
babies to the closest 100 g. For the mothers and fathers, a 
calibrated scale (Seca model 220) is used. Participants are 
asked to remove their shoes as well as any heavy clothing 
(jeans, jacket, scarf and so on). For babies, a calibrated 
scale (model Seca 336) is used and they are weighed 
without any clothes or nappy.
Height is measured in mothers, fathers as well as length 
in babies to the closest mm. For the mothers and fathers, 
a calibrated scale (Seca model 220) is used and they are 
asked to remove their shoes. For babies, a calibrated scale 
(Seca model 336) is used. The infant’s head is placed 
against the head positioner (Seca model 419), then the 
experimenter lightly presses on the infant’s knees and 
measures the infant’s length with the measuring rod 
(Seca model 232).
Total fat mass of the mother and her offspring are 
measured with BIA and skinfolds. BIA measures the 
reactance and the resistance of the patient.173 Any 
metallic objects such as watches, bracelets or others 
are removed before starting the BIA. The participant 
needs to lie down, arms and legs spread away from 
each other, so that there is no contact between the 
limbs. Four electrodes are positioned; two on the 
right hand and two on the right foot, at a distance 
of 3–4 cm from each other (BIA 101, Akern, Italy). 
Obese women with an altered body composition can 
be identified and monitored using vector BIA.174 
A relaxation phase of 10 min is respected before 
measurements are taken. Skinfolds are measured 
with a Harpenden skinfold calliper (HSK-BI, British 
Indicators, UK) on the biceps, the triceps, the 
subscapular and the iliac crest. Muscle tissues are not 
included in the skinfolds. Measures for the mothers 
are taken on the right side of the body while standing 
up. Measurements are taken twice, and a third time 
if the difference between the two first measures is 
over 1 mm. A mean between the two or three values 
is calculated.175 176 For the babies, the measures are 
taken once on the left hand side while their mothers 
are holding them.177
Total and regional fat mass measured by Dual-Energy 
X-ray absorptiometry (mother). Participants are asked 
to remove all metal items before densitometry and are 
examined while wearing only their underwear and a 
cloth gown. The subjects are placed in a supine position 
with their arms at their sides but held slightly separated 
from their trunk and correctly centred on the scanning 
field. Regions of interest are defined by the analytical 
programme, and include different corporeal districts: 
total body, trunk, head, pelvic, upper limbs, lower limbs, 
android and gynoid region. For each region, DXA scans 
bone mineral content, bone areal size and weight (in 
grams) of total mass, FM and non-bone lean mass. For the 
android and gynoid regions, the ratio between android 
and gynoid fat distribution is also assessed. Also calcu-
lated are a FM index (kg/m2), computed as the ratio of 
total body FM over height squared and a skeletal muscle 
mass index (kg/m2), computed as the ratio of appendic-
ular skeletal muscle mass over height squared. Finally, the 
intravisceral fat index is assessed using a special algorithm 
provided by the manufacturer.
Blood pressure in mothers and their partners is measured 
by obtaining three readings at 2 min intervals with a 
clinically validated oscillometric sphygmomanometer 
(OMRON HEM-907, Japan).
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Laboratory variables
Mother
Cardiometabolic laboratory variables such as HbA1c, 
lipid levels, gamma-GT, B12 vitamin, ferritin will be 
measured at study beginning, at 6–8 weeks and at 
1 year postpartum and miRNA will be additionally 
also measured at birth. At 6–8 weeks and at 1 year 
postpartum, a 75 g oGTT with blood sampling at 
30 min intervals for 2 hour will be performed to assess 
glucose tolerance and indices of insulin secretion and 
sensitivity.
Offspring
Cord blood sample will be obtained at the time of 
birth to measure lipid levels, glucose, HbA1c and 
other cardiometabolic laboratory parameters as well 
as miRNA (for more details, see Di Bernardo et al142). 
A sample of the respective blood draw will be kept for 
future potential analyses.
sample size calculation
Sample size was computed based on the expected 
difference in primary outcomes between the control 
and the intervention group. The weight assumptions 
are based on our pilot data and goals for weight reten-
tion. Regarding maternal weight, we assumed a weight 
reduction of 8.4 kg (SD: 5.5) between study enrol-
ment at 24–32 GA, after GDM diagnosis and 1 year 
postpartum in women allocated to the control group 
compared with a weight reduction of 10.9 kg (SD: 5.5) 
in women allocated to the intervention group. The 
required sample size is 76 women in each study group 
to have a statistical significant difference with a power 
of 80% and an alpha-level set at 0.05 (two-sided).
This sample size is also sufficient to observe statis-
tical significant differences in the reduction in the 
Edinburgh Postnatal Depression symptoms score, if 
we assume that the reduction in depression symptoms 
score between the above-mentioned two time points is 
0.2 (SD: 4.3) in women allocated to the control group 
and 2.2 (SD: 4.4) in women allocated to the interven-
tion group. Assuming a maximum attrition rate of 
30%, we will include 100 women in the control and 
100 in the intervention groups to provide adequate 
power.
stAtIstICAL AnALysIs
For the primary aim, differences in the changes in 
maternal weight and the EPDS symptoms score between 
enrolment after GDM diagnosis and 1 year postpartum at 
the end of the study between the intervention and the 
control group will be analysed using linear regression 
analysis. For the secondary aims, the analyses will be 
performed both for differences in changes between the 
intervention and the control group and for differences 
between groups at different time points (baseline at 
inclusion, childbirth, 6–8 weeks and 1 year postpartum) 
in maternal metabolic health outcomes, maternal mental 
health outcomes and offspring metabolic and mental 
health outcomes. This will be tested using linear regres-
sion analysis. We will compare the proportion of patients 
meeting guidelines for gestational weight gain and for 
weight retention at 1 year postpartum between the two 
groups using logistic regression analyses. Associations 
between outcomes will be tested using linear regression 
analyses.
Differences between groups will be adjusted for the 
respective baseline values in case they differ. Vari-
ables will be transformed if residuals are not normally 
distributed. We will include potential confounding 
variables, if necessary. These include maternal age, 
sex of the children, the presence of prenatal, peri-
natal and early postnatal conditions/complications, 
BMI, EPDS symptoms score and socioeconomic 
status where applicable. Subgroup analyses will be 
performed according to weight status, mental health 
status (EPDS score <10 vs ≥10), prediabetes status at 
the initial postpartum evaluation (6–8 weeks post-
partum) as well as sex (for the children). Analyses 
will be conducted with STATA V.14.0. For confirma-
tory analyses, a Bonferroni correction for multiple 
analyses will be applied. For initial exploratory anal-
yses, no such correction will be used.178 For the part-
ners, we will evaluate changes between groups and 
differences between groups at different time points 
(baseline at inclusion, 1 year postpartum) in weight 
and paternal eating behaviour and mental health 
outcomes.
Finally, a process evaluation nested inside the trial will 
be conducted in order to assess fidelity and quality of 
implementation, to clarify causal mechanisms and to 
identify contextual factors associated with variation in 
outcomes.179
AdvErsE EvEnts
All expected and unexpected adverse events will be 
recorded during the entire study period. A recognised 
potential risk is the occurrence of early contractions 
due to intense physical activity. In order to monitor 
and mitigate this potential risk, patients will be closely 
supervised by a physician and a physiotherapist. In case 
of early contractions, participants will be requested to 
reduce or stop their physical activity.
dAtA MAnAGEMEnt
All study data will be entered by research staff (PhD 
students and study co-ordinator). All data will be 
precoded and stored in a secured database (Secutrial), 
which will be regularly updated by the IT Service of the 
Lausanne University Hospital. Double data entry will be 
done for the primary outcomes. For the rest of the data, 
a random 5% will be double-checked.
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MonItorInG
Monitoring will be performed by a qualified person 
independent of the study group and will be organ-
ised in two parts: the initial visit took place before 
the start of recruitment and the second visit after 
approximately 10% of the study population have been 
recruited.
EthICs And dIssEMInAtIon
The trial poses little to no risk to participants and 
their offspring. Signed informed consent is obtained 
from all participating women. Participation in the 
study does not interfere with the typical care patients 
receive during pregnancy and after childbirth. Results 
from this study will be disseminated at regional and 
international conferences and in peer-reviewed jour-
nals. The MySweetHeart Trial is a registered trial ( clin-
icaltrials. gov/ ct2/ show/ NCT02890693) and linked to 
the MySweetHeart Cohort ( clinicaltrials. gov/ ct2/ show/ 
NCT02872974).
sIGnIfICAnCE And outLook
This project will provide relevant findings regarding 
understanding of GDM, potential pathways and its 
link to lifestyle, mental health and the development 
and trajectories of obesity and diabetes in the mothers 
and obesity in their offspring. It will also provide rele-
vant findings regarding treatment of GDM and its 
impact on complications such as diabetes and obesity 
and may thus help to elucidate potential solutions, 
thus leading to significant changes in clinical practice 
and guidelines.
Due to its interdisciplinary nature, this research is 
of interest for clinicians, educators and researchers in 
the field of diabetes, obstetrics, paediatrics and devel-
opment, psychology, sport and nutrition sciences and 
public health.
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